However, this p53-induced anti-tumor activity of Rbm24 and Rbm38 needs to be reconciled with their oncogenic potential, which is related to their repressive function on p53 mRNA translation and p53-dependent apoptosis [26,38]. The gene discussed is RBM24; the disease is neoplasm.